Riskpilot← Back to searchSign inGet full accessROCHE DIAGNOSTICS NORGE AS
ASActiveOrg 987852208Brynsengfaret 6B, 0667 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 200599 employeeswww.roche-diagnosticsnorge.no
Revenue 2024
NOK 628M
+3% vs 2023
EBITDA margin
4.4%
-7% vs 2023
Equity ratio
43.6%
Financial strength
Net profit 2024
NOK 11,2M
-29% vs 2023
| Revenue | NOK 628M | +3% |
| EBITDA | NOK 27,3M | -7% |
| Net profit | NOK 11,2M | -29% |
| Total assets | NOK 279,9M | +16% |
| Equity | NOK 122,1M | +11% |
| Employees | 99 | — |
Legal name
ROCHE DIAGNOSTICS NORGE AS
Org number
987852208
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. februar 2005
Share capital
NOK 5 840 000
Employees
99 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Markedsføring og salg av farmasøytiske og kjemiske produkter samt deltakelse i andre aktiviteter i tilknytning til dette gjennom egenkapitalinnskudd, lån eller garantier.
Address
Brynsengfaret 6B, 0667 Oslo
Phone
+4723373300
Website
www.roche-diagnosticsnorge.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 643 118 | 1 372 515 | 2 255 325 | 608 846 | 628 014 |
| Staff expenses | −115 807 | −133 255 | −129 021 | −124 267 | −138 147 |
| EBITDA | 32 913 | 25 944 | 111 711 | 29 409 | 27 322 |
| Depreciation & amort. | −8 519 | −5 254 | −10 361 | −12 866 | −13 333 |
| EBIT | 24 394 | 20 690 | 101 350 | 16 543 | 13 989 |
| Net financials | 633 | 603 | 3 779 | 4 904 | 1 118 |
| Profit before tax | 25 027 | 21 293 | 105 129 | 21 447 | 15 107 |
| Tax | 5 880 | 5 129 | 23 623 | 5 769 | 3 899 |
| Net profit | 19 147 | 16 164 | 81 506 | 15 678 | 11 208 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 343 077 | 653 557 | 362 681 | 241 276 | 279 850 |
| Equity | 96 560 | 112 725 | 94 230 | 109 908 | 122 139 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 246 517 | 540 832 | 268 450 | 131 368 | 157 711 |
| Total debt | 246 517 | 540 832 | 268 450 | 131 368 | 157 711 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
43.6%
This company
38.2%
Market median
+14% vs market
20202024
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
20202024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20202024
Asset turnover
2.24×
This company
1.12×
Market median
+100% vs market
20202024
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
DA Chief Executive Officer | Chief Executive Officer | 2017 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2024 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Chairman | 2022 – 2024 | |
| Chairman | 2019 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Roche Holding | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ROCHE DIAGNOSTICS NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Andrzej Malarek | Chief Executive Officer | 0 companies |
| Martin Wiliam George Haswell | Board of Directors | 0 companies |
| Jakob Rosenkilde Butina | Chairman | 0 companies |
| Paula Aguiar | Chairman | 0 companies |
| Jens Ragnar Jensen | Chairman | 0 companies |
| Bernard Maurice Georges Colombo | Board of Directors | 0 companies |
| Nabeeha Qazi | Board of Directors | 0 companies |